Compare LCTX & FUNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LCTX | FUNC |
|---|---|---|
| Founded | 1990 | 1900 |
| Country | United States | United States |
| Employees | N/A | 343 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 255.4M | 282.0M |
| IPO Year | 1996 | 2012 |
| Metric | LCTX | FUNC |
|---|---|---|
| Price | $0.96 | $42.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.25 | N/A |
| AVG Volume (30 Days) | ★ 976.9K | 20.3K |
| Earning Date | 05-14-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 2.80% |
| EPS Growth | N/A | ★ 19.68 |
| EPS | N/A | ★ 1.90 |
| Revenue | $14,556,000.00 | ★ $18,426,000.00 |
| Revenue This Year | $109.40 | $13.05 |
| Revenue Next Year | N/A | $6.56 |
| P/E Ratio | ★ N/A | $22.98 |
| Revenue Growth | ★ 53.24 | 4.01 |
| 52 Week Low | $1.00 | $33.54 |
| 52 Week High | $2.09 | $46.30 |
| Indicator | LCTX | FUNC |
|---|---|---|
| Relative Strength Index (RSI) | 43.43 | N/A |
| Support Level | $1.02 | N/A |
| Resistance Level | $1.18 | N/A |
| Average True Range (ATR) | 0.05 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 18.75 | 0.00 |
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.
First United Corp is active in the financial services domain. The scope of its offering includes checking, savings, money market deposit accounts and certificates of deposit, business loans, personal loans, mortgage loans and lines of credit extended to both individuals and businesses. The bank also provides residential real estate construction loans to builders and individuals for single-family dwellings. The company's reportable operating segments include community banking and wealth management. The company generates the majority of its revenue from the Community Banking segment, which is engaged in delivering financial products and services, including various loan and deposit products, to consumer, business, and not-for-profit customers.